UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P1001: DNMT3A/TET2/ASXL1 MUTATIONS DETERMINE THROMBOTIC RISK IN POLYCYTHAEMIA VERA

HemaSphere, 2022-06, Vol.6 (Suppl), p.891-892

2022

Volltextzugriff (PDF)

Analysis of CGG variation through 642 meioses in Fragile X families

Molecular human reproduction, 2004-10, Vol.10 (10), p.773-776

2004

Volltextzugriff (PDF)

An IPSS-R Cutoff Point of 3 Stratified Chronic Myelomonocytic Leukemia Patients Into Two Risk Groups

Leukemia research, 2017-04, Vol.55, p.S144-S145

2017

Volltextzugriff (PDF)

An IPSS-R Cutoff Point of 3 Stratified Myelodysplastic Syndromes Patients Into Two Risk Groups

Leukemia research, 2017-04, Vol.55, p.S145-S146

2017

Volltextzugriff (PDF)

SCA8 in the Spanish population including one homozygous patient

Clinical genetics, 2002-11, Vol.62 (5), p.404-409

2002

Volltextzugriff (PDF)

Spanish Guidelines for the use of Targeted Deep Sequencing in MDS and CMML

Leukemia research, 2017-04, Vol.55, p.S16-S16

2017

Volltextzugriff (PDF)

Characteristics and Prognosis of Patients Diagnosed with AML and MDS Who Were Excluded from Clinical Trials. A Retrospective Single-Center Analysis

Leukemia research, 2017-04, Vol.55, p.S52-S53

2017

Volltextzugriff (PDF)

PS1196 INNOVATIVE DIAGNOSTIC APPROACH FOR RARE ANEMIA

HemaSphere, 2019-06, Vol.3 (S1), p.545-n/a

2019

Volltextzugriff (PDF)

Topic: AS07-Singular Entities/Subtypes/AS07c-Hereditary MDS including predisposition syndromes: HIGH PREVALENCE OF IDIOPATHIC DYPSLASIA OF UNDETERMINED SIGNIFICANCE (IDUS) AND CLONAL HEMATOPOIESIS OF INDETEMINATE POTENTIAL (CHIP) AMONG RELATIVES OF HEMATOLOGIC NEOPLASMS WITH GERMLINE PREDISPOSITION PATIENTS

Leukemia research, 2023-05, Vol.128, p.107249, Article 107249

2023

Volltextzugriff (PDF)

Pilot study for the neonatal screening of fragile X syndrome

Prenatal diagnosis, 2002-06, Vol.22 (6), p.459-462

2002

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: BONE MARROW MICROENVIRONMENT CHANGES IN MYELODYSPLASTIC NEOPLASMS AND ITS RELATIONSHIP WITH CLONAL HEMATOPOIESIS

Leukemia research, 2023-05, Vol.128, p.107209, Article 107209

2023

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: BONE MARROW CYTOKINES AND CHEMOKINES CONCENTRATIONS IN MYELODISPLASTIC NEOPLASMS

Leukemia research, 2023-05, Vol.128, p.107210, Article 107210

2023

Volltextzugriff (PDF)

PB1657 SHOULD THE B‐CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH MATURE PHENOTYPE AND KMT2A REARRANGEMENTS BE CONSIDERED AS A NEW ENTITY?

HemaSphere, 2019-06, Vol.3 (S1), p.766-767

2019

Volltextzugriff (PDF)

The Alport syndrome

Nefrología, 2003, Vol.23 Suppl 1, p.29

2003

Volltextzugriff (PDF)

Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: CLINICAL AND CARDIOVASCULAR RISK ASSESSMENT OF SUBJECTS WITH JAK2-V617F CLONAL HEMATOPOIESIS

Leukemia research, 2023-05, Vol.128, p.107240, Article 107240

2023

Volltextzugriff (PDF)

Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: PREVALENCE, DYNAMICS AND CLINICAL SIGNIFICANCE OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IN NEWLY DIAGNOSED CANCER PATIENTS

Leukemia research, 2023-05, Vol.128, p.107244, Article 107244

2023

Volltextzugriff (PDF)

PF541 TRANSCRIPTIONAL ALTERATIONS OF HEMATOPOIETIC STEM CELLS IN MYELODYSPLASTIC SYNDROMES

HemaSphere, 2019-06, Vol.3 (S1), p.223-n/a

2019

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation

Leukemia research, 2021-09, Vol.108, p.106681, Article 106681.31

2021

Volltextzugriff (PDF)

P31 - Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation: PHENOTYPE AND GENOTYPE OF NATURAL KILLERS IN MYELODISPLASITIC SYNDROME

Leukemia research, 2021-09, Vol.108

2021

Volltextzugriff (PDF)

TRANSCRIPTIONAL ALTERATIONS OF HEMATOPOIETIC STEM CELLS IN MYELODYSPLASTIC SYNDROMES: PF541

HemaSphere, 2019-06, Vol.3, p.223

2019

Volltextzugriff (PDF)

P30 - Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation: RELATION BETWEEN INMUNE CELL POPULATIONS AND MALIGNANT CLONE MUTATIONAL STATUS IN MYELODYSPLASTIC SYNDROMES

Leukemia research, 2021-09, Vol.108

2021

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation

Leukemia research, 2021-09, Vol.108, p.106681, Article 106681.30

2021

Volltextzugriff (PDF)

Collagen type IV (α3–α4) nephropathy: from isolated haematuria to renal failure

Nephrology, dialysis, transplantation, 2004-10, Vol.19 (10), p.2429-2432

2004

Volltextzugriff (PDF)

253 - An IPSS-R Cutoff Point of 3 Stratified Myelodysplastic Syndromes Patients Into Two Risk Groups

Leukemia research, 2017-04, Vol.55, p.S145-S146

2017

Volltextzugriff (PDF)

252 - An IPSS-R Cutoff Point of 3 Stratified Chronic Myelomonocytic Leukemia Patients Into Two Risk Groups

Leukemia research, 2017-04, Vol.55, p.S144-S145

2017

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(51)
Tagungsberichte
(8)

Sprache

Englisch
(53)
Spanisch
(6)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

P1001: DNMT3A/TET2/ASXL1 MUTATIONS DETERMINE THROMBOTIC RISK IN POLYCYTHAEMIA VERA

Analysis of CGG variation through 642 meioses in Fragile X families

An IPSS-R Cutoff Point of 3 Stratified Chronic Myelomonocytic Leukemia Patients Into Two Risk Groups

An IPSS-R Cutoff Point of 3 Stratified Myelodysplastic Syndromes Patients Into Two Risk Groups

SCA8 in the Spanish population including one homozygous patient

Spanish Guidelines for the use of Targeted Deep Sequencing in MDS and CMML

Characteristics and Prognosis of Patients Diagnosed with AML and MDS Who Were Excluded from Clinical Trials. A Retrospective Single-Center Analysis

PS1196 INNOVATIVE DIAGNOSTIC APPROACH FOR RARE ANEMIA

Pilot study for the neonatal screening of fragile X syndrome

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: BONE MARROW MICROENVIRONMENT CHANGES IN MYELODYSPLASTIC NEOPLASMS AND ITS RELATIONSHIP WITH CLONAL HEMATOPOIESIS

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: BONE MARROW CYTOKINES AND CHEMOKINES CONCENTRATIONS IN MYELODISPLASTIC NEOPLASMS

PB1657 SHOULD THE B‐CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH MATURE PHENOTYPE AND KMT2A REARRANGEMENTS BE CONSIDERED AS A NEW ENTITY?

The Alport syndrome

Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: CLINICAL AND CARDIOVASCULAR RISK ASSESSMENT OF SUBJECTS WITH JAK2-V617F CLONAL HEMATOPOIESIS

Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: PREVALENCE, DYNAMICS AND CLINICAL SIGNIFICANCE OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IN NEWLY DIAGNOSED CANCER PATIENTS

PF541 TRANSCRIPTIONAL ALTERATIONS OF HEMATOPOIETIC STEM CELLS IN MYELODYSPLASTIC SYNDROMES

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation

P31 - Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation: PHENOTYPE AND GENOTYPE OF NATURAL KILLERS IN MYELODISPLASITIC SYNDROME

TRANSCRIPTIONAL ALTERATIONS OF HEMATOPOIETIC STEM CELLS IN MYELODYSPLASTIC SYNDROMES: PF541

P30 - Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation: RELATION BETWEEN INMUNE CELL POPULATIONS AND MALIGNANT CLONE MUTATIONAL STATUS IN MYELODYSPLASTIC SYNDROMES

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation

Collagen type IV (α3–α4) nephropathy: from isolated haematuria to renal failure

253 - An IPSS-R Cutoff Point of 3 Stratified Myelodysplastic Syndromes Patients Into Two Risk Groups

252 - An IPSS-R Cutoff Point of 3 Stratified Chronic Myelomonocytic Leukemia Patients Into Two Risk Groups

Suchergebnisse filtern